|
 |
|
|||||||
|
|||||||||
Diabetes 51:2301-2305, 2002
© 2002 by the American Diabetes Association, Inc.
Loss of Kinase Activity in a Patient With Wolcott-Rallison Syndrome Caused By a Novel Mutation in the EIF2AK3 Gene
From the University Children’s Hospital, Division of Pediatric Endocrinology/Diabetology, Zurich, Switzerland
Wolcott-Rallison syndrome (WRS) is an autosomal recessive disorder characterized by neonatal or early infancy type 1 diabetes, epiphyseal dysplasia, and growth retardation. Mutations in the EIF2AK3 gene, encoding the eukaryotic initiation factor 2
-kinase 3 (EIF2AK3), have been found in WRS patients. Here we describe a girl who came to our attention at 2 months of age with severe hypertonic dehydration and diabetic ketoacidosis. A diagnosis of type 1 diabetes was made and insulin treatment initiated. Growth retardation and microcephaly were also present. Anti-islet cell autoantibodies were negative, and mitochondrial diabetes was excluded. Imaging revealed a hypoplastic pancreas and typical signs of spondylo-epiphyseal dysplasia. The diagnosis of WRS was therefore made at age 5 years. Sequencing analysis of her EIF2AK3 gene revealed the presence of a homozygous T to C exchange in exon 13 leading to the missense serine 877 proline mutation. The mutated kinase, although it partly retains the ability of autophosphorylation, is unable to phosphorylate its natural substrate, eukaryotic initiation factor 2 (eIF2). This is the first case in which the pathophysiological role of EIF2AK3 deficiency in WRS is confirmed at the molecular level. Our data demonstrate that EIF2AK3 kinase activity is essential for pancreas islet function and bone development in humans, and we suggest EIF2AK3 as a possible target for therapeutic intervention in diabetes.
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  J R Porter and T G Barrett Monogenic syndromes of abnormal glucose homeostasis: clinical review and relevance to the understanding of the pathology of insulin resistance and {beta} cell failure J. Med. Genet., December 1, 2005; 42(12): 893 - 902. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Koster, M. A. Permutt, and C. G. Nichols Diabetes and Insulin Secretion: The ATP-Sensitive K+ Channel (KATP) Connection Diabetes, November 1, 2005; 54(11): 3065 - 3072. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Biason-Lauber, D. Konrad, F. Navratil, and E. J. Schoenle A WNT4 Mutation Associated with Mullerian-Duct Regression and Virilization in a 46,XX Woman N. Engl. J. Med., August 19, 2004; 351(8): 792 - 798. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Kloting, B. Wilke, and I. Kloting Phenotypic and genetic analyses of subcongenic BB.SHR rat lines shorten the region on chromosome 4 bearing gene(s) for underlying facets of metabolic syndrome Physiol Genomics, August 11, 2004; 18(3): 325 - 330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Senee, K. M. Vattem, M. Delepine, L. A. Rainbow, C. Haton, A. Lecoq, N. J. Shaw, J.-J. Robert, R. Rooman, C. Diatloff-Zito, et al. Wolcott-Rallison Syndrome: Clinical, Genetic, and Functional Study of EIF2AK3 Mutations and Suggestion of Genetic Heterogeneity Diabetes, July 1, 2004; 53(7): 1876 - 1883. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Brickwood, D T Bonthron, L I Al-Gazali, K Piper, T Hearn, D I Wilson, and N A Hanley Wolcott-Rallison syndrome: pathogenic insights into neonatal diabetes from new mutation and expression studies of EIF2AK3 J. Med. Genet., September 1, 2003; 40(9): 685 - 689. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |